Current status of and future perspectives for platinum antitumor drugs
Yakugaku Zasshi: Journal of the Pharmaceutical …, 2008 - europepmc.org
Cisplatin, a simple inorganic compound, has been one of the leading antitumor drugs for
near 30 years. However, cisplatin has several drawbacks such as toxicity and drug …
near 30 years. However, cisplatin has several drawbacks such as toxicity and drug …
Current status of and future perspectives for platinum antitumor drugs
M Chikuma, T Sato, S Komeda - … zasshi: Journal of the …, 2008 - pubmed.ncbi.nlm.nih.gov
Cisplatin, a simple inorganic compound, has been one of the leading antitumor drugs for
near 30 years. However, cisplatin has several drawbacks such as toxicity and drug …
near 30 years. However, cisplatin has several drawbacks such as toxicity and drug …